A study regarding the interrelation between subclinical hypothyroidism & insulin resistance among PCOS women
Keywords:
Polycystic Ovary Syndrome, sub clinical hypothyroidism, Insulin resistanceAbstract
Background: Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder (5-10%) in women of reproductive age. It is characterized by clinical and biochemical hyperandrogenism, menstrual irregularities, infertility and metabolic syndrome. Hypothyroidism is more common in PCOS. Subclinical hypothyroidism may aggravate insulin resistance. Objective: To find any relationship between subclinical hypothyroidism and Insulin resistance in PCOS patients. Materials and Methods: Study Design: A hospital based cross sectional study, Study Subjects: PCOS cases fulfilling the inclusion and exclusion criteria, SAMPLE SIZE: 100 PCOS cases attending to Gynaecology OPD, Study Setting: Gynaecology OPD of a Medical College hospital, Study Duration: January 2015 to August 2016. This included all PCOS patients, who had the criteria of Rotterdam for PCOS. Clinical examination, height, weight, BMI and lab data were measured including thyroid hormone and biochemical profile. Data were analysed by SPSS software version 21. Results: Out of 100 study subjects 52 were Euthyroid (TSH < 5) and 48 were SCH (TSH ≥ 5). Fasting serum Insulin, and HOMA IR were significantly elevated in SCH group compared to Euthyroid group (p = < 0.05.).
Downloads
References
Anahita Enzevaei, Saghar Salehpour, Maryam Tohidi, Nasrin Saharkhiz. Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship? Iran J Reprod Med 2014 July; 12(7): 481-6.
Barter PJ, Brewer Jr HB, Chapman MJ, Henneckens CH, Rader DJ, Tall AR. Cholesteryl ester transfer protein, a novel target for raising HDL and inhibiting atheroscelerosis. Arterioscler Thromb Vasc Biol 2003; 23:160-7.
Berek JS, Novak’s Gynaecology. Endocrine disorders, 14th edition 2007: 1076-88.
Ciaraldi TP, Aroda V, Mudaliar S, Chang RJ, Henry RR. Polycystic ovary syndrome is associated with tissue specific differences in insulin resistance. J Clin Endocrinol Metab 2009; 94: 157-163.
Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. EndocrineReviews 1997; 18(6):774–800.
Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352:1223-36.
Eirini Maratou, Dimitrios J Hadjidakis, Anastasios Kollias et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. European Journal of Endocrinology 2009; 160:785 – 90.
Erel CT, Senturk LM, Kaleli S, Gezer A, Baysal B, Tasan E. Is serum leptin level regulated by thyroid function, lipid metabolism and insulin resistance in poly cystic ovary syndrome? Gynecol Endocrinol 2003; 17: 223-9.
Fritz MA, Speroff L. Chronic anovulation and the polycystic ovary in Clinical Gynecologic Endocrinology and Infertility. Lippincott Williams & Wilkins, New York,NY,USA, 2011; 8th edition: 495–531.
Gateva A, Kamenov Z. Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity. Obstet Gynecol Int 2012;Article ID:306347 ,11 pages. doi:10.1155/2012/306347.
Herman, H., Ardani, I. G. A. I., Aryani, L. N. A., Windiani, I. G. A. T., Adnyana, I. G. N. S., & Setiawati, Y. (2022). Signs and symptoms of depression in children and adolescents with type 1 diabetes mellitus: A case report. International Journal of Health & Medical Sciences, 5(1), 150-153. https://doi.org/10.21744/ijhms.v5n1.1861
Pallotti S, Gasbarrone A, Franzese IT. Relationship between insulin secretion, and thyroid and ovary function in patients suffering from polycystic ovary. Minerva Endocrinol 2005; 30: 193-7.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Uzunlulu M, Yorulmaz E, Oguz A. Prevalence of subclinical hypothyroidism in patients with metabolic syndrome. Endocr J 2007; 54: 71-6.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
